AstraZeneca partners with CSPC Pharmaceuticals for drug discovery collaboration

From Yahoo Finance: 2025-06-30 11:31:00

AstraZeneca PLC (NASDAQ:AZN) is one of the 11 Best Strong Buy Stocks to Invest in Now. The company has entered a strategic research collaboration with CSPC Pharmaceuticals Group Limited to develop novel oral candidates for various diseases. CSPC will conduct research in Shijiazhuang City using an AI-driven drug discovery platform.

The agreement aims to discover pre-clinical candidates for chronic diseases treatment. A pre-clinical small molecule oral therapy for immunological diseases is part of the research focus. AstraZeneca PLC’s presence in China is set to expand with this collaboration, following a $2.5 billion investment in a new global R&D center in Beijing.

AstraZeneca PLC is a biopharmaceutical company that develops and commercializes prescription medicines for various health conditions. The company supplies its products to specialty and primary care physicians through local offices and distributors. While AZN shows investment potential, some AI stocks may offer greater upside and less risk.

For more insights on potential investments, check out reports on the best short-term AI stock, the Best and Worst Dow Stocks for the Next 12 Months, and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

Read more: AstraZeneca (AZN) Announces Strategic Research Collaboration with CSPC Pharmaceuticals